CVS Health (CVS)
$65.19
0.71 (1.09%)
CVS Stock Quote Delayed 30 Minutes
CVS Health Shares Rally on Better-Than-Expected Earnings
CVS Health (CVS) stock was up on Wednesday following the release of its earnings report for the second quarter of the year.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$63.86
Market Cap
81.30B
PE Ratio
17.83
EPS
3.656
Volume (Avg. Vol.)
8.12M
Day's Range
$63.76 - $65.03
52-Week Range
$42.93 - $77.01
Dividend & Yield
$2.66 (4.08%)
CVS Stock Predictions, Articles, and CVS Health News
CVS Apologizes After Denying Prescription to Transgender Woman
CVS (CVS) is issuing an apology after a pharmacist at the company refused to fulfill a prescription for a transgender woman in Spring.
5 Stocks Trading Near 52-Week High With More Room to Run
Here are some stocks trading near their 52-week high levels with potential to scale higher. Compare Brokers....
3 Big Stock Charts for Friday: Sherwin-Williams, Regeneron and Allstate
These three stock charts have the makings and markings of trade set-ups. Here's why, and how to best play them in this unusual environment.
Amazon Shakes Up Drugstore Industry With PillPack Deal
Amazon (AMZN) just gained nearly $20 billion in the pharmaceutical industry's market share after acquiring PillPack, while Walgreens, CVS and Rite Aid lost a combined $11 billion.
5 Top Stock Trades for Friday — Amazon Disrupts Pharmacy Industry
Amazon is entering the pharmacy space, crushing the stocks of Walgreens and CVS Health. And those are just a few of our top stock trades for Friday.
CVS Rolls Out Prescription Drug Delivery Program
CVS (CVS) is now offering a prescription drug delivery service to its customers and it includes same-day delivery in some areas.
Trade of the Day: AmerisourceBergen Corporation (ABC)
The surprise judgment on Tuesday in favor of the AT&T (T)/Time Warner (TWX) merger is probably going to give media stocks a small boost in the short term, but another stock that could benefit from the shift in favor of larger mergers is AmerisourceBergen Corporation (ABC).
Sell CVS Health Corp and Express Scripts Holding Company as Trump Readies Attack
The Trump administration is targeting PBMs, so it's time to sell PBM stocks, including CVS stock and Express Scripts stock.
5 Top Stock Trades for Monday Morning
The markets had a big week and bulls are looking to press their luck and fatten their wallets. Here are our top stock trades for Monday.
Earnings Show CVS Health Corp on Track To Benefit From Transformation
CVS is moving ahead with Aetna deal as CVS stock trades at a decades-low PE and with dividend yields near record highs.
Anthem Inc Is Boring, But Profitable
ANTM is a boring stock but that does not exclude it from being a great one. After the first quarter results and 2018 outlook, investors should take a look at this company.
Earnings Season Is Keeping the Markets Wobbly
When the Fed didn't raise rates, the stock market settled back into its most recent pattern of uneasiness.
3 Reasons to Consider Buying CVS Health Stock Before Earnings
CVS Health stock is looking like an attractive name for bulls. It's got a low valuation, decent growth and a 3% dividend. Too bad CVS stock is almost $10 off its recent low.
Aetna Inc (AET) Slims and Trims Before Marriage to CVS
There's no particular reason to buy AET stock now, but CVS shareholders have good reason to be excited about the Aetna merger.
Aetna Inc Stock Is Low-Risk, Big-Reward at Current Levels
AET stock is priced as if it doesn't have a sizable M&A catalyst on the table, but it does, and that makes the stock an attractive option at current levels.
